Promising advances in ovarian cancer chemotherapy

Abbie L. Fields; Gary L. Goldberg; Patrick Anderson; Carolyn D. Runowicz

Promising advances in ovarian cancer chemotherapy

Abbie L. Fields, Gary L. Goldberg, Patrick Anderson, Carolyn D. Runowicz

Obstetrics & Gynecology and Women's Health

Research output: Contribution to journal › Article › peer-review

Abstract

Although ovarian cancer is a devastating disease, we can now offer hope as agents with unique mechanisms of action are developed and elicit favorable response rates in clinical trials.

Original language	English (US)
Pages (from-to)	81-100
Number of pages	20
Journal	Contemporary Ob-Gyn
Volume	42
Issue number	7
State	Published - 1997

ASJC Scopus subject areas

Obstetrics and Gynecology
Advanced and Specialized Nursing
Maternity and Midwifery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{d7c17fb97d46469abb89afc24e337919,

title = "Promising advances in ovarian cancer chemotherapy",

abstract = "Although ovarian cancer is a devastating disease, we can now offer hope as agents with unique mechanisms of action are developed and elicit favorable response rates in clinical trials.",

author = "Fields, {Abbie L.} and Goldberg, {Gary L.} and Patrick Anderson and Runowicz, {Carolyn D.}",

year = "1997",

language = "English (US)",

volume = "42",

pages = "81--100",

journal = "Contemporary Ob-Gyn",

issn = "0090-3159",

publisher = "Advanstar Communications",

number = "7",

}

TY - JOUR

T1 - Promising advances in ovarian cancer chemotherapy

AU - Fields, Abbie L.

AU - Goldberg, Gary L.

AU - Anderson, Patrick

AU - Runowicz, Carolyn D.

PY - 1997

Y1 - 1997

N2 - Although ovarian cancer is a devastating disease, we can now offer hope as agents with unique mechanisms of action are developed and elicit favorable response rates in clinical trials.

AB - Although ovarian cancer is a devastating disease, we can now offer hope as agents with unique mechanisms of action are developed and elicit favorable response rates in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0347076290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347076290&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0347076290

SN - 0090-3159

VL - 42

SP - 81

EP - 100

JO - Contemporary Ob-Gyn

JF - Contemporary Ob-Gyn

IS - 7

ER -

Promising advances in ovarian cancer chemotherapy

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this